Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UKAntev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent PaymentsJune 30, 2025 7:30 AM EDT | Source: Medicus Pharma Ltd.Philadelphia, Pennsylvania--(Newsfile Corp. - June 30, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus") and Antev Ltd. ("Antev"), a UK-based clinical-stage drug development company, announced today that they have entered into a definitive agreement da ...